Curing Type 1 diabetes has been a primary goal for stem-cell research since the mid 1990s, but experts say scientists are still years away from success. In this article from the Los Angeles Times, a journalist talks to researchers about the simplicity of the concept, and why getting cells to become insulin-producers is so difficult in reality.
ABC News recently aired an item that discussed the tuberculosis (TB) risk in children and adolescents that may have caused alarm for... Read more »
I recently received the following e-mail:"I'm a 17 year old diabetic who has been following the research and hoping that stem cells will be... Read more »
For years, it has been the position of both the American Diabetes Association and the Juvenile Diabetes Research Foundation that stem cell... Read more »
Let me start by pointing out that I am easily frustrated by rat and other rodent-research. It's all too common that a story gets planted in... Read more »
This is a new idea I've put together on condensing some of the research that may be of interest, but perhaps doesn't deserve a full post.... Read more »
A new study found that 20 out of 23 Type 1 diabetics who were given stem cell transplants did not need to take insulin for two to four years. The... Read more »
Drugmaker Pfizer has bought the rights to a controversial stem cell therapy that may one day treat inflammatory bowel disease (IBD). The stem cells,... Read more »
Scientists have found that infusing multiple sclerosis (MS) patients with their own immune stem cells appears to help the immune system "reset"... Read more »
Source: ADAM Encyclopedia
A stem cell is a generic cell that can make exact copies of itself indefinitely. A stem cell has the ability to produce specialized cells for various... Read more »